FDA Seizes All Drugs From Generics Maker

Agency cites poor quality at Michigan plants, warns of potential shortage of one pain reliever THURSDAY, June 25 (HealthDay News) -- The seizure of all drugs and drug ingredients at a Michigan-based manufacturer by the U.S. Food and Drug Administration could lead to a shortage of a par...

BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program

BCBSNC customers saved at least $15 million in out-of-pocket costs since January; 2.4 million generic prescriptions filled with no copay; Customers have until June 30,2009 to save with the generic copay waiver program Chapel Hill, NC (Vocus) June 1, 2009 -- Blue Cross ...

GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs

WASHINGTON, May 6 /PRNewswire/ -- The Generic Animal Drug Alliance (GADA), an independent professional trade organization representing generic animal health industry interests, says that the recent tragic deaths of 21 horses in Wellington, Florida illustrates the potential safety issues surroundin...

Prasco Selected as GSK's Generics Marketing and Distribution Agent

Fluticasone Propionate Nasal Spray (FLONASE(R)) will be the first product marketed under this arrangement MASON, Ohio, March 11 /PRNewswire/ -- Prasco Laboratories , announced today it has entered into a marketing and distribution agreement with GlaxoSmithKline (NYSE: GSK ). FLONASE(R) (f...

BCBSNC Helps Customers Fight Recession With Free Generics

BCBSNC waives copayments for generic prescriptions from Jan 1 - June 30, 2009; BCBSNC's 2008 "Medication Dedication" program has helped customers stick with their medicines and save a total of $13 million on out-of-pocket costs; The 2009 generic copay waiver program applies to about 1 m...

Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report

Branded Pharmaceutical companies can expect to see sales drops of up to 70 percent after patent expiration from Generic competition NEW YORK, LONDON and TOKYO, July 14 /PRNewswire/ -- Branded Pharmaceutical companies are painfully aware of the astronomical growth of Generics competition....

Thomson Reuters Introduces a New Solution to Boost Competitive Advantage in China's Generics and API Market

Industry Leader in Generic Market Information Offers Newport Horizon Premium SHANGHAI, China, June 24 /Xinhua-PRNewswire/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced at CPhI China 2...

Independence Blue Cross Waives Copays for Generics Used to Treat Certain Chronic Conditions

Rx for Better Health offers members access to 75 generic drugs at no cost for six months PHILADELPHIA, June 19 /PRNewswire/ -- Independence Blue Cross (IBC) will waive copays and coinsurance on 75 generic drugs that are used to treat common chronic conditions. Rx for...

Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA

PITTSBURGH, June 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL ) today announced that it has acquired Merck KGaA's Central & Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic. As announced previously, Mylan exe...

Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry

Report Draws On Strategic Intelligence and Competitive Analysis Information From Newport Horizon Global(TM) PHILADELPHIA and LONDON, Jan. 9 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC ; TSX: TOC) and leading provider of information...

generics in Medical Technology

Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237

...s strategy. Vectura has development collaborations with several pharmaceutical companies, including Boehringer Ingelheim, Novartis, Sandoz (the generics arm of Novartis), Baxter, GlaxoSmithKline (GSK), Mylan, UCB and Otsuka. Vectura has been included in the FTSE 250 index since 23 March 2009. For furth...

VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful

...fter switching between different generic formulations of an AED. "Brand names of medications have different formulations than their generics, and generics also vary from each other-in the exact amount of active ingredients in the drug as well as with the amount and type of filler ingredients included. Th...

Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms

... dysfunction (4.7 percent) and erectile dysfunction (5.8 percent) for those switching to generic 5-ARIs. "This preliminary study shows that some generics are not as effective as their branded counterparts and that men should consult a physician if a generic alternative is not providing results. Given th...

CVS Caremark Study Finds Non-Adherent Heart Failure Patients Almost Twice as Likely to be Re-Hospitalized Within a Year

...bout how to manage side effects and stay on therapy; If cost is an issue, talk to your health care provider or pharmacist about whether less expensive generics are available and Sign-up for an auto-refill program with your retail or mail-order pharmacy to keep your prescription refills on track and on time." ...

NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium

...uisition of Innovata in January 2007 brought established alliances with a number of additional companies, such as Baxter, GlaxoSmithKline (GSK), Merck generics (part of Mylan Inc), UCB and Otsuka, as well as providing revenue streams, complementary products and critical mass. For further information, please v...

Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use

... of Michigan, Ann Arbor, Michigan. "There are strategies to minimize or reverse GI injury, especially as many of the medications become less costly as generics become available." These recommendations are part of an ongoing dialogue between the three collaborating organizations and, according to the authors...

New Pharma Business Model Increases Pressure on Staff Communicating Trial Data

... CHAPEL HILL, N.C., May 23 /PRNewswire/ -- With increased FDA scrutiny around new medicines and heightened competition from generics in the pharmaceutical market, marketing teams and science staff have to be even more delicate when communicating clinical trial results of new drugs i...

Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill

...an said. * Help get affordable generic medicines on the market more quickly by blocking the frivolous use of citizen petitions to delay the entry of generics on the market. Only three of 42 citizen petitions answered between 2001 and 2005 raised issues that merited changes in the agency's policies about a d...

IMPAX Presents at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders

...pecialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and markets its bra...

generics in Medical Dictionary

Prescription

...ete ownership, whereas prescription bestows an easement. ... Drug Discount Card. Fertility Program. Caremark Specialty Pharmacy. Accordant Care. generics ... Copyright © 2009 Caremark, L.L.C. ... But if your prescription lenses are made for indoors, wearing them for sun will ... Why not have the b...

Generic

...cribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than ... New Drug Application (ANDA): generics . Orange Book Query ... the Director, Office of Generic Drugs ... Office of Generic Drugs: Chemistry and Bioequivalence ... Dictionary.com - L...

generics in Biological Technology

Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period

Sees opportunity to end abusive use of authorized generics during period of exclusivity PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- Mylan Inc.'s (Nasdaq: MYL ) Chief Operating Officer Heather Bresch today testified before the U.S. House of Representatives Judiciary Subcommittee on Courts a...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...Total Brands $340,341 $282,174 Total generics $30,284 $23,987 Total Royalty and Ot...Total Brands $631,951 $550,652 Total generics $72,677 $45,780 Total Royalty and Ot...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...cy basis would have been approximately 13%. generics revenues, which are derived from sales in North Am...ements that had been previously deferred. generics revenues were $2.06 billion in the six months ende...ssociated with the integration of the former Merck generics business. Partially offsetting these favorable it...

"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila

...USA and Europe. The awareness of generics in Japan is comparatively low and generics are still largely perceived as cheaper, low quality alternatives to patente...nwide promotion and awareness campaign regarding the safety and efficacy of generics however is expected to change this perception and usage in future. Z...

Sanofi-aventis Announces Second Quarter 2009 Results

...he acquisition(3) of Shantha Biotechnics in India; generics business more than tripled in size with the integr...es of the product reflect ongoing competition from generics in Europe, and were down 4.3% at euro 353 million....anting summary judgment motions brought by certain generics companies in the U.S. Eloxatin((R)) patent litigat...

Simcere Pharmaceutical Group Notice of Annual General Meeting

...and first-to-market generics, and has introduced an innovative anti-cancer medication Endu, a first-to-market medication Sinofuan, and first-to-market generics such as Bicun and Anxin. Simcere manufactures and sells antibiotics, anti-cancer medication and stroke management medication. Simcere concentrates its...

GPhA Calls Senate HELP Committee Action Disappointing for Countless Patients

...icans are struggling to pay for the medicines they need. "With generics saving the health care system $734 billion in the last decade, the House mu...ls, and suppliers of other goods and services to the generic drug industry. generics represent 69% of the total prescriptions dispensed in the United States, bu...

GPhA Says BIO Cries Wolf on Senate Biogenerics Proposal

...icals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. generics represent 69% of the total prescriptions dispensed in the United States, but only 16% of all dollars spent on prescription drugs. For more information...

Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)

...o IMS Health. Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generics and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest -- and highest quality -- product portfolios...

Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

...ther witness, a shift in terms of market growth from matured markets towards emerging markets. Patent expiries of major drugs, and subsequent entry of generics that are priced lower, increasing pressure to contain costs, along with increased healthcare legislation and safety scrutiny are slowing down growth i...